Description
Neurotransmitters + UDH III
A specialized urine test panel that measures metabolites of key
neurotransmitters including serotonin, dopamine, norepinephrine, epinephrine,
GABA, glutamate, and histamine, along with advanced urinary dopamine
metabolites such as 3-methoxytyramine (3-MT), 3,4-dihydroxyphenylacetic acid
(DOPAC), and homovanillic acid (HVA). This comprehensive analysis provides
detailed insights into dopamine synthesis, metabolism, and breakdown pathways,
supporting evaluation of nervous system health, mood regulation, cognitive
function, and neurodegenerative risk. It is particularly useful for diagnosing
and managing conditions like Parkinson’s disease, mood disorders, ADHD,
chronic fatigue, and other neurological or psychiatric disorders. The test
enables personalized therapeutic approaches through nutrition, supplements,
and lifestyle modifications aimed at optimizing neurotransmitter balance and
dopamine metabolism.
Categories by Disease
- Neurodegenerative diseases (Parkinson’s, Lewy body dementia)
- Mood and anxiety disorders
- Neurodevelopmental conditions (ADHD, autism spectrum)
- Chronic fatigue syndrome and fibromyalgia
- Stress-related hormonal and neurotransmitter imbalances
Categories by Symptoms
- Motor dysfunctions such as tremors, rigidity
- Anxiety, depression, mood swings
- Cognitive impairment, poor concentration
- Fatigue and low motivation
- Sleep disturbances and restlessness
Categories by Lifestyle
- Exposure to neurotoxins or heavy metals
- Chronic psychological or physical stress
- Poor nutrition affecting neurotransmitter synthesis
- Use of medications altering dopamine pathways
- Sleep deprivation and circadian rhythm disruptions
Categories by Diagnostic Methods
-
Urine analysis using high-performance liquid chromatography (HPLC) or mass
spectrometry quantifying neurotransmitter metabolites including 3-MT, DOPAC,
and HVA -
Provides detailed functional assessment of dopamine metabolism and overall
neurotransmitter status
